Publications4 June 2021/in News/by Jan GroenView some publications in which DGr Pharma is involved… Bradykinin Challenge Provides Surrogate Endpoints For Hereditary Angioedema TreatmentUsing Bradykinin-B2-Receptor Antagonists PHA-022121, a Selective Bradykinin-B2-Receptor Antagonist, Is Safe and Shows Rapid Oral Bioavailability in Humans https://www.dgrpharma.com/cms19/wp-content/uploads/2021/06/Insights-into-Drug-Discovery-and-Development-2025-9.png 625 1875 Jan Groen https://www.dgrpharma.com/cms19/wp-content/uploads/2025/09/DGr-Pharma-logo-1-300x150.png Jan Groen2021-06-04 08:36:022025-09-09 21:20:12Publications
GLP